Wolverine Asset Management Expands Stake in Chemours by 136%

Wolverine Asset Management LLC has significantly increased its stake in The Chemours Company, raising its ownership by an impressive 136.1% during the second quarter of 2025, according to a recent filing with the Securities and Exchange Commission (SEC). Following this increase, the institutional investor now holds 89,718 shares of the specialty chemicals firm, valued at approximately $1,027,000.

Several other institutional investors have also made notable adjustments to their positions in Chemours. Peregrine Capital Management LLC raised its stake by 20.0%, acquiring an additional 64,218 shares, which brings its total to 385,664 shares, worth around $4,416,000. Similarly, the Teacher Retirement System of Texas boosted its holdings by 15.1%, adding 8,917 shares to reach a total of 67,911 shares, valued at $778,000.

Nisa Investment Advisors LLC made an even larger adjustment, increasing its stake by 105.0% to own 41,382 shares, worth approximately $474,000. Other firms, including Ingalls & Snyder LLC and Moloney Securities Asset Management LLC, have also initiated new positions in Chemours, worth $241,000 and $352,000, respectively. Collectively, institutional investors now own 76.26% of Chemours’ shares.

CEO Investment and Insider Activity

In a separate development, CEO Denise Dignam acquired 4,068 shares of Chemours on August 8, 2025. The shares were purchased at an average price of $12.06 each, totaling approximately $49,060. Following this transaction, Dignam’s ownership increased to 191,546 shares, valued at around $2,310,044.76. This transaction was disclosed in a filing with the SEC, indicating a 2.17% increase in her stake.

Stock Performance and Earnings Report

The stock of Chemours opened at $13.35 on August 8, 2025, reflecting a range between a 52-week low of $9.13 and a high of $22.38. The company has a market capitalization of $2.00 billion, with a price-to-earnings ratio of -4.77 and a beta of 1.65.

Chemours reported its earnings results on August 5, 2025, revealing earnings of $0.58 per share. This figure surpassed analysts’ expectations of $0.46 by $0.12. The company achieved revenue of $1.62 billion, exceeding forecasts of $1.57 billion and marking a 5.0% increase compared to the same quarter last year, when it earned $0.38 per share.

Looking ahead, Chemours has set its guidance for the third quarter of 2025 at an expected earnings per share of $2.03 for the current year.

Upcoming Dividend Announcement

Additionally, Chemours has announced a quarterly dividend of $0.0875 per share, scheduled for payment on December 15, 2025. Investors of record on November 14, 2025 will be eligible to receive this dividend, resulting in an annualized yield of 2.6%.

The company’s current dividend payout ratio stands at -12.50%, indicating a focus on maintaining liquidity amid its growth strategies.

Chemours operates within the specialty chemicals sector, providing performance chemicals globally across North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. Its business segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, with products widely used in various applications, including coatings, packaging, and more.

For further insights into Chemours and its market activities, investors can explore the latest filings and updates available through the SEC and other financial news platforms.